Reda A Eissa

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer

A. Ghallab, Reda A Eissa, H. M. El Tayebi, 2022, Frontiers in Pharmacology.